123 related articles for article (PubMed ID: 1438929)
1. High dose rate gynecological applications--radiobiological considerations based on the alpha-beta model.
Ling CC; Sahoo N; Leibel S; Anderson LL
Radiother Oncol; 1992 Oct; 25(2):103-10. PubMed ID: 1438929
[TBL] [Abstract][Full Text] [Related]
2. Analysis of factors affecting the therapeutic gain in high dose rate gynecological implants relative to low dose rate implants.
Sahoo N; Ling CC; Anderson LL
Med Phys; 1996 Mar; 23(3):419-25. PubMed ID: 8815385
[TBL] [Abstract][Full Text] [Related]
3. HDR versus LDR gynecological brachytherapy revisited.
Scalliet P; Gerbaulet A; Dubray B
Radiother Oncol; 1993 Aug; 28(2):118-26. PubMed ID: 8248552
[TBL] [Abstract][Full Text] [Related]
4. The use of small fraction numbers in high dose-rate gynaecological afterloading: some radiobiological considerations.
Dale RG
Br J Radiol; 1990 Apr; 63(748):290-4. PubMed ID: 2346867
[TBL] [Abstract][Full Text] [Related]
5. High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience.
Petereit DG; Sarkaria JN; Potter DM; Schink JC
Int J Radiat Oncol Biol Phys; 1999 Dec; 45(5):1267-74. PubMed ID: 10613322
[TBL] [Abstract][Full Text] [Related]
6. Low-dose-rate brachytherapy is superior to high-dose-rate brachytherapy for bladder cancer.
Pos FJ; Horenblas S; Lebesque J; Moonen L; Schneider C; Sminia P; Bartelink H
Int J Radiat Oncol Biol Phys; 2004 Jul; 59(3):696-705. PubMed ID: 15183473
[TBL] [Abstract][Full Text] [Related]
7. Determination of the appropriate fraction number and size of the HDR brachytherapy for cervical cancer.
Liu WS; Yen SH; Chang CH; Yang KM; Wu YP; Chen KY
Gynecol Oncol; 1996 Feb; 60(2):295-300. PubMed ID: 8631555
[TBL] [Abstract][Full Text] [Related]
8. Radiobiological equivalent of low/high dose rate brachytherapy and evaluation of tumor and normal responses to the dose.
Manimaran S
Radiat Med; 2007 Jun; 25(5):229-35. PubMed ID: 17581712
[TBL] [Abstract][Full Text] [Related]
9. High dose rate versus low dose rate brachytherapy in the treatment of tongue carcinoma - a radiobiological study.
Petera J; Matula P; Paluska P; Sirak I; Macingova Z; Kasaova L; Frgala T; Hodek M; Vosmik M
Neoplasma; 2009; 56(2):163-8. PubMed ID: 19239332
[TBL] [Abstract][Full Text] [Related]
10. Biological effective dose evaluation in gynaecological brachytherapy: LDR and HDR treatments, dependence on radiobiological parameters, and treatment optimisation.
Bianchi C; Botta F; Conte L; Vanoli P; Cerizza L
Radiol Med; 2008 Oct; 113(7):1068-78. PubMed ID: 18618074
[TBL] [Abstract][Full Text] [Related]
11. [The radiobiology of gynecologic HDR and LDR afterloading technics].
Bauer M; Schulz-Wendtland R
Rontgenblatter; 1989 Jan; 42(1):54-6. PubMed ID: 2645638
[TBL] [Abstract][Full Text] [Related]
12. LDR vs. HDR brachytherapy for localized prostate cancer: the view from radiobiological models.
King CR
Brachytherapy; 2002; 1(4):219-26. PubMed ID: 15062170
[TBL] [Abstract][Full Text] [Related]
13. Pulsed dose rate and fractionated high dose rate brachytherapy: choice of brachytherapy schedules to replace low dose rate treatments.
Visser AG; van den Aardweg GJ; Levendag PC
Int J Radiat Oncol Biol Phys; 1996 Jan; 34(2):497-505. PubMed ID: 8567354
[TBL] [Abstract][Full Text] [Related]
14. Comparison of Nucletron and ROCS brachytherapy treatment planning systems for LDR and HDR applications.
Ho AK; Sibata CH; Shin KH
Med Dosim; 1994; 19(3):147-9. PubMed ID: 7818754
[TBL] [Abstract][Full Text] [Related]
15. Biologically effective doses in medium dose rate brachytherapy of cancer of the cervix.
Leborgne F; Fowler JF; Leborgne JH; Zubizarreta E; Chappell R
Radiat Oncol Investig; 1997; 5(6):289-99. PubMed ID: 9436246
[TBL] [Abstract][Full Text] [Related]
16. [HDR or LDR in gynecological brachytherapy?].
Prager W
Strahlenther Onkol; 1994 Jun; 170(6):368. PubMed ID: 8023249
[No Abstract] [Full Text] [Related]
17. High-dose versus low-dose rate brachytherapy in definitive radiotherapy of cervical cancer.
Kucera H; Pötter R; Knocke TH; Baldass M; Kucera E
Wien Klin Wochenschr; 2001 Jan; 113(1-2):58-62. PubMed ID: 11233470
[TBL] [Abstract][Full Text] [Related]
18. Modelling second malignancy risks from low dose rate and high dose rate brachytherapy as monotherapy for localised prostate cancer.
Murray L; Mason J; Henry AM; Hoskin P; Siebert FA; Venselaar J; Bownes P;
Radiother Oncol; 2016 Aug; 120(2):293-9. PubMed ID: 27370205
[TBL] [Abstract][Full Text] [Related]
19. [Pulsed dose brachytherapy--a review of clinical applications in the treatment of gynecological malignancies].
Skowronek J; Roszak A; Cikowska-Woźniak E
Ginekol Pol; 2005 Aug; 76(8):661-70. PubMed ID: 16363375
[TBL] [Abstract][Full Text] [Related]
20. Patterns of brachytherapy practice for patients with carcinoma of the cervix (1996-1999): a patterns of care study.
Erickson B; Eifel P; Moughan J; Rownd J; Iarocci T; Owen J
Int J Radiat Oncol Biol Phys; 2005 Nov; 63(4):1083-92. PubMed ID: 16099599
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
